You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 4, April 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Enzyme Level Changes in the Cerebrospinal Fluid of Patients With Acute Stroke

Per Vaagenes, MD; Petter Urdal, MD; Ronald Melvoll, MD; Kolbjørn Valnes, MD

Arch Neurol. 1986;43(4):357-362.


Abstract

• Creatine kinase (CK), brain CK (CKBB), lactate dehydrogenase (LD), and aspartate aminotransferase (ASAT) levels were determined in cerebrospinal fluid (CSF) obtained from 35 patients with acute stroke. In patients with transient, minor neurological disturbances, only LD levels increased; in those who remained comatose and died, the levels of all the enzymes, except ASAT, increased. Patients who remained with focal motor defects had increased CK and LD levels, while CKBB and ASAT levels were variable. In most of the CSF samples, muscle CK activity was also detectable, suggestive of a leakage from blood to CSF. The pattern of the enzyme increase could be related to the causative mechanisms for the strokes. The study suggests that CSF enzyme determinations may provide supplementary information as to the extent and severity of brain damage and the recovery potentials of selected patient groups with strokes.



Author Affiliations

From the Department of Anesthesiology, Akershus Central Hospital, Nordbyhagen, Norway and University of Oslo (Dr Vaagenes); the Departments of Clinical Chemistry (Dr Urdal) and Medicine IX (Dr Valnes), Ulleval Hospital, Oslo and University of Oslo; and the Department of Anesthesiology, Vest-Agder Central Hospital, Kristiansand, Norway (Dr Melvoll).


Footnotes

Accepted for publication Aug 19, 1985.

Reprint requests to Department of Anesthesiology, Akershus Central Hospital, 1474 Nordbyhagen, Norway (Dr Vaagenes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Proteomic Analysis of Cerebrospinal Fluid Changes Related to Postmortem Interval
Finehout et al.
Clin. Chem. 2006;52:1906-1913.
ABSTRACT | FULL TEXT  

Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke: A Pilot Study
Zimmermann-Ivol et al.
Mol. Cell. Proteomics 2004;3:66-72.
ABSTRACT | FULL TEXT  

Neuron-Specific Enolase in Gerbil Brain and Serum After Transient Cerebral Ischemia
Horn et al.
Stroke 1995;26:290-297.
ABSTRACT | FULL TEXT  

Neurological Outcome After Out-of-Hospital Cardiac Arrest: Prediction by Cerebrospinal Fluid Enzyme Analysis
Roine et al.
Arch Neurol 1989;46:753-756.
ABSTRACT  

Creatine Kinase Activity in Cerebrospinal Fluid-Reply
Vaagenes and Urdal
Arch Neurol 1987;44:472-472.
ABSTRACT  

Creatine Kinase Activity in Cerebrospinal Fluid
Chandler et al.
Arch Neurol 1987;44:471-472.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.